Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Johnson & johnson symbols : Fnctf save search
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-07 (Crawled : 21:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -2.28%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.63%
H: 0.0%
C: 0.0%
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: 0.27%
H: 20.82%
C: 11.51%
year pharmaceuticals financial results
Vanda Pharmaceuticals Announces a U.S. Patent Allowance for PONVORY® (ponesimod) in the U.S.
Published: 2024-01-26 (Crawled : 04:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: 0.79%
H: 1.05%
C: -1.83%
ponvory patent pharmaceuticals
Acute Ischemic Stroke Diagnosis and Treatment Market to Reach $9.2 Billion, Globally, by 2032 at 6.1% CAGR: Allied Market Research
Published: 2023-12-14 (Crawled : 01:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -1.89%
H: 0.0%
C: 0.0%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 1.19%
H: 3.09%
C: 1.3%
SYK | $325.43 -0.62% 0.0% 1.8M
|
Health Technology
|
| O: 0.16%
H: 0.52%
C: -0.64%
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: 1.05%
H: 2.38%
C: 0.81%
PHG | $19.98 0.0% 540K
|
Health Technology
|
| O: 4.96%
H: 1.5%
C: 0.91%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 1.81%
H: 0.0%
C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 1.78%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.21%
H: 0.27%
C: -0.52%
stroke reach treatment research market
Vanda Pharmaceuticals Acquires U.S. and Canadian Rights to PONVORY® (ponesimod), a Selective S1P1R Modulator Approved for Patients with Relapsing Multiple Sclerosis
Published: 2023-12-07 (Crawled : 12:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.61%
H: 0.0%
C: 0.0%
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: 6.68%
H: 1.39%
C: -7.89%
ponvory approved sclerosis pharmaceuticals
Body Lotion Market to Reach $85.3 billion, Globally, by 2032 at 4.3% CAGR: Allied Market Research
Published: 2023-12-05 (Crawled : 07:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -1.09%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: 0.0%
COTY | $11.15 1.0% 0.0% 6.2M
|
Consumer Non-Durables
|
| O: -1.1%
H: 0.77%
C: -1.79%
reach research market
Shoulder Arthroscopy Market to Reach $712.12 Million, globally, by 2032 at 5.1% CAGR: Allied Market Research
Published: 2023-11-22 (Crawled : 06:00) - prnewswire.com
SYK | $325.43 -0.62% 0.0% 1.8M
|
Health Technology
|
| O: 0.66%
H: 0.29%
C: -0.52%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.92%
H: 0.0%
C: 0.0%
CNMD | $72.64 2.2% 0.0% 500K
|
Health Technology
|
| O: 1.0%
H: 0.48%
C: -1.31%
CNMD | $72.64 2.2% -1.98% 500K
|
Health Technology
|
| O: 1.0%
H: 0.48%
C: -1.31%
reach research market
HIV Drugs Market to Reach $51.1 Billion, Globally, by 2032 at 4.5% CAGR: Allied Market Research
Published: 2023-11-17 (Crawled : 16:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.78%
H: 0.0%
C: 0.0%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.69%
H: 0.06%
C: -0.68%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.5%
H: 0.82%
C: 0.75%
reach research hiv market
Surgical Equipment Market to Reach $59 Billion, Globally, by 2032 at 5.2% CAGR: Allied Market Research
Published: 2023-10-31 (Crawled : 14:00) - prnewswire.com
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: -0.09%
H: 1.49%
C: 0.93%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
CNMD | $72.64 2.2% 0.0% 500K
|
Health Technology
|
| O: 0.74%
H: 1.39%
C: -0.84%
BSX | $67.33 -0.13% -0.31% 7M
|
Health Technology
|
| O: 0.7%
H: 2.1%
C: 1.57%
CNMD | $72.64 2.2% -1.98% 500K
|
Health Technology
|
| O: 0.74%
H: 1.39%
C: -0.84%
reach research market
Advanced Wound Care and Closures Market to Reach $32.9 Billion, Globally, by 2032 at 5.4% CAGR: Allied Market Research
Published: 2023-10-26 (Crawled : 00:00) - prnewswire.com
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: 1.01%
H: 0.48%
C: -2.32%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -2.35%
H: 0.0%
C: 0.0%
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
|
| O: 0.71%
H: 0.26%
C: -1.59%
MMM | $92.27 0.86% -0.18% 3.6M
|
Producer Manufacturing
|
| O: 0.53%
H: 0.13%
C: -1.8%
IART | $28.68 -9.33% -10.29% 2.9M
|
Health Technology
|
| O: 0.45%
H: 0.64%
C: -4.15%
reach care research market
Healthcare Finance Solutions Market to Reach $276.04 billion, Globally, by 2032 at 9.3% CAGR: Allied Market Research
Published: 2023-09-08 (Crawled : 15:30) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: 1.47%
H: 0.0%
C: -2.56%
PHG | $19.98 0.0% 540K
|
Health Technology
|
| O: -2.02%
H: 0.62%
C: -0.43%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.34%
H: 0.0%
C: 0.0%
CBSH 4 | $53.85 1.41% 1.39% 770K
|
Finance
|
| O: 0.41%
H: 0.79%
C: 0.45%
reach research solutions market
Sunless Tanners Global Market Report 2023: Advanced Formulas and Technologies Boost Growth
Published: 2023-05-26 (Crawled : 23:00) - prnewswire.com
EPC 4 | $36.65 1.41% 0.0% 260K
|
Consumer Non-Durables
| Email alert
Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
| Email alert
Add to watchlist
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
UL | News | $47.31 0.98% 0.02% 5M
|
Consumer Non-Durables
| Email alert
Add to watchlist
UNLYF | News | $47.95 1.3% 740
|
Consumer Non-Durables
| Email alert
Add to watchlist
report global growth market
Open Book Extracts Announces Allen Olson as VP of Supply Chain
Published: 2023-04-25 (Crawled : 12:20) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.38%
H: 0.63%
C: 0.53%
ERLEADA® (apalutamide), First-and-Only Next-Generation Androgen Receptor Inhibitor with Once-Daily, Single-Tablet Option Now Available in the U.S.
Published: 2023-04-03 (Crawled : 16:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.03%
H: 1.33%
C: 1.23%
erleada
Real-World Study Shows Patients Treated with IMBRUVICA® (ibrutinib) Were Less Likely to Initiate a Next-Line Treatment than Patients on Acalabrutinib in First-line Chronic Lymphocytic Leukemia
Published: 2022-12-12 (Crawled : 17:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.12%
H: 1.09%
C: 1.07%
imbruvica treatment leukemia study
New Results from the Phase 3 GLOW Study of Fixed-Duration Treatment with IMBRUVICA® (ibrutinib) Plus Venetoclax Demonstrate Robust Efficacy and Sustained Response in Older, Unfit Patients with Previously Untreated Chronic Lymphocytic Leukemia
Published: 2022-12-10 (Crawled : 16:20) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
| Email alert
Add to watchlist
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
imbruvica treatment glow leukemia response plus results study
TUT Fitness Group Expands Strategic Advisory Board
Published: 2022-11-10 (Crawled : 11:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
group
Janssen to Highlight Latest Scientific Advances in Hematologic Diseases at ASH 2022 with Clinical and Real-World Data Across Innovative Pipeline and Distinguished Portfolio
Published: 2022-11-03 (Crawled : 16:00) - prnewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -2.44%
H: 5.65%
C: 5.65%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -1.73%
H: 4.51%
C: 3.15%
U.S. FDA Approves IMBRUVICA® (ibrutinib) as First and Only BTKi Treatment for Pediatric Patients with Chronic Graft-Versus-Host Disease
Published: 2022-08-24 (Crawled : 00:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
imbruvica treatment fda disease
Global Sunless Tanners Market Trajectory & Analytics 2022-2026: Concerns over Skin Cancer Move UV-Free Tanners Demand in Upward Trajectory
Published: 2022-06-23 (Crawled : 11:00) - prnewswire.com
UNLYF | News | $47.95 1.3% 740
|
Consumer Non-Durables
|
| O: 2.72%
H: 0.0%
C: -1.86%
UL | News | $47.31 0.98% 0.02% 5M
|
Consumer Non-Durables
|
| O: -0.07%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 2.76%
H: 0.0%
C: 0.0%
EPC 4 | $36.65 1.41% 0.0% 260K
|
Consumer Non-Durables
|
| O: -0.24%
H: 2.88%
C: 2.58%
analytics skin cancer market
BioSpace Movers & Shakers: ADC, Akari, Scorpion & More
Published: 2022-06-17 (Crawled : 13:00) - biospace.com/
CMRA | $0.041 70.59% 2K
|
n/a
|
| O: -5.71%
H: 49.39%
C: 34.55%
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -4.49%
H: 0.0%
C: 0.0%
LZAGF | $563.5 -19.1% 6
|
Health Technology
|
| O: 0.24%
H: 0.0%
C: 0.0%
LZAGY | $55.65 0.02% 32K
|
Professional, Scientific, and T...
|
| O: 0.58%
H: 1.5%
C: 0.83%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 1.35%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
BSX | $67.33 -0.13% -0.31% 7M
|
Health Technology
|
| O: 1.69%
H: 2.14%
C: 1.18%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
KUKE | $2.88 2.49% 7.64% 360K
|
CXM 4 | $11.34 -0.44% 4.27% 1.7M
|
Information
BSBR | $5.25 2.54% 0.38% 430K
|
Finance
JOE 4 | $54.88 1.22% 0.22% 210K
|
Finance
JBI 4 | $15.14 1.34% 0.0% 2.9M
|
Your saved searches
Save your searches and get alerts when important news are released.